Loading…

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

THE immunosuppressive drugs cyclosporin A (CsA) and FKS06 both interfere with a Ca 2+ -sensitive T-cell signal transduction pathway 1–4 thereby preventing the activation of specific transcription factors (such as NF-AT and NF-IL2A) 1,5–7 involved in lymphokine gene expression. CsA and FK506 seem to...

Full description

Saved in:
Bibliographic Details
Published in:Nature (London) 1992-06, Vol.357 (6380), p.695-697
Main Authors: Clipstone, Neil A, Crabtree, Gerald R
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:THE immunosuppressive drugs cyclosporin A (CsA) and FKS06 both interfere with a Ca 2+ -sensitive T-cell signal transduction pathway 1–4 thereby preventing the activation of specific transcription factors (such as NF-AT and NF-IL2A) 1,5–7 involved in lymphokine gene expression. CsA and FK506 seem to act by interaction with their cognate intracellular receptors 8–10 , cyclophilin and FKBP, respectively (see ref. 11 for review). The Ca 2+ /calmodulin-regulated phosphatase calcineurin is a major target of drug-isomerase complexes in vitro 12 We have therefore tested the hypothesis that this interaction is responsible for the in vivo effects of CsA/FK506. We report here that overexpression of calcineurin in Jurkat cells renders them more resistant to the effects of CsA and FK506 and augments both NFAT- and NFIL2A-dependent transcription. These results identify calcineurin as a key enzyme in the T-cell signal transduction cascade and provide biological evidence to support the notion that the interaction of drug-isomerase complexes with calcineurin underlies the molecular basis of CsA/FK506-mediated immunosuppression.
ISSN:0028-0836
1476-4687
DOI:10.1038/357695a0